---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295453702.md"
description: "Corbus Pharmaceuticals (CRBP) shares fell 6.98% to $9.46 on Monday, underperforming competitors like Vanda and Fortress Biotech which saw gains. The decline ended a four-day winning streak and occurred amidst a broader market dip. Trading volume was below the 50-day average. CRBP remains significantly below its 52-week high."
datetime: "2026-08-10T21:22:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295453702.md)
  - [en](https://longbridge.com/en/news/295453702.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295453702.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) shed 6.98% to $9.46 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.32% to 26,605.36 and Dow Jones Industrial Average falling 0.11% to 53,975.98.

The stock's fall snapped a four-day winning streak.

Corbus Pharmaceuticals Holdings Inc. closed 53.99% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. (VNDA) rose 0.40% to $5.02, Fortress Biotech Inc. (FBIO) rose 3.00% to $2.75, and Viking Therapeutics Inc. (VKTX) rose 0.53% to $34.44.

Trading volume (335,694) remained 76,998 below its 50-day average volume of 412,692.

Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-10-26 1722ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CRBP Stock News](https://longbridge.com/en/news/296118418.md)
- [Corbus Pharma CFO Sean Moran sells 12,000 shares for $120,971](https://longbridge.com/en/news/295447150.md)
- [Corbus Pharma CMO Nicacio Leonardo Viana files initial beneficial ownership statement](https://longbridge.com/en/news/294867785.md)
- [Corbus Chief Business Officer Nishant Saxena acquires 2,600 shares worth $25,037.44](https://longbridge.com/en/news/295706183.md)
- [Pacira BioSciences CMO Jonathan Slonin sells 3,040 shares for $70,619.20](https://longbridge.com/en/news/296271811.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**